A recent report published in GIE: Gastrointestinal Endoscopy, the scientific journal of the ASGE, discusses the role various technologies play in monitoring endoscope reprocessing quality.
Emerging technologies
• Microbial culture: Culturing for bacterial load
• Bioburden assays: Evaluating residual bioburden and organic matter
• Adenosine triphosphate bioluminescence testing: Testing for ATP bioluminescence, which is present in microorganisms and human cells
Future research
• Establishment and validation of bioburden/microbial benchmarks
• Establishment and validation of ATP bioluminescence thresholds after reprocessing
• Assessment of cost-effectiveness of endoscope reprocessing surveillance strategies
• Large prospective studies to assess clinical and cost-effective value of various surveillance technologies
• Potentially incorporating bioburden/microbial assessments into automated endoscope reprocessors
More articles on gastroenterology:
TIF vs. traditional surgical GERD treatment: 7 things to know
Are surveillance colonoscopy practices due for an update?
5 things to know about colonoscopy payment: AGA bundle vs. Medicare model
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
